PRKAA2 and diabetic cardiomyopathy: Using AMPK deficient mice and chemical activators of AMPK such as AICAR and MET, numerous studies have shown that AMPK exerts a cardioprotective effect against myocardial ischemic injury (110, 111), diabetic cardiomyopathy (112), pathological cardiac remodeling (113), and heart failure (109).